Skip to main content

Table 1 Baseline characteristics of patients with SCLC

From: Causes of death following small cell lung cancer diagnosis: a population-based analysis

Characteristic

Diagnosed cases, n

Deaths, n

Mean age at death, y

Deaths by time after diagnosis, n (%)

 < 1 y

1–3 y

 > 3 y

All patients

44,506

42,476

66.75

29,536 (69.5)

11,040 (26.0)

1900 (4.5)

Sex

Male

22,521

21,606

66.36

15,662 (72.5)

5173 (23.9)

771 (3.6)

Female

21,985

20,870

67.14

13,874 (66.5)

5867 (28.1)

1129 (5.4)

Age at diagnosis, y

< 60

11,389

10,566

53.41

6434 (60.9)

3558 (33.7)

574 (5.4)

60–69

15,496

14,731

64.66

9873 (67.0)

4129 (28.0)

729 (4.9)

≥ 70

17,621

17,179

76.74

13,229 (77.0)

3353 (19.5)

597 (3.5)

Race

White

38,373

36,684

66.85

25,603 (69.8)

9458 (25.8)

1623 (4.4)

Black

4512

4306

65.01

2920 (67.8)

1180 (27.4)

206 (4.8)

Other

1621

1486

69.37

1013 (68.2)

402 (27.1)

71 (4.8)

Cancer stage

I–III

15,591

14,180

6721

7574 (53.4)

5176 (36.5)

1430 (10.1)

IV

28,915

28,296

6652

21,962 (77.6)

5864 (20.7)

470 (1.7)

Treatment

Surgery

1114

877

6620

339 (38.7)

386 (44.0)

152 (17.3)

Radiotherapy

20,498

19,028

6454

10,586 (55.6)

6957 (36.6)

1485 (7.8)

Chemotherapy

31,154

29,408

6507

17,711 (60.2)

9979 (33.9)

1718 (5.8)